# A Multicenter Study Evaluating the Diagnostic Value of 68Ga-MY6349 PET/CT for Prostate Cancer

> **NCT06696326** · NA · RECRUITING · sponsor: **The First Affiliated Hospital of Xiamen University** · enrollment: 100 (estimated)

## Conditions studied

- Positron-Emission Tomography(PET)
- Prostate Cancer
- Trophoblast Cell Surface Antigen 2

## Interventions

- **DIAGNOSTIC_TEST:** standard-of-care imaging 68Ga-MY6349 and 68Ga-PSMA-11

## Key facts

- **NCT ID:** NCT06696326
- **Lead sponsor:** The First Affiliated Hospital of Xiamen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-01
- **Primary completion:** 2025-10-15
- **Final completion:** 2025-10-15
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06696326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06696326, "A Multicenter Study Evaluating the Diagnostic Value of 68Ga-MY6349 PET/CT for Prostate Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06696326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*